- The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes
-
Shlofmitz , Shlofmitz , Lee MS
- KMID: 2456861
- Korean Circ J.
- 2019 Aug;49(8):645-656.
- doi: 10.4070/kcj.2019.0185
The number of patients undergoing percutaneous coronary intervention (PCI) who mandate additional oral anticoagulant therapy has been increasing. Dual antiplatelet therapy (DAPT) is associated with reduced ischemic events including stent... -
- CITED
-
- Close
- SHARE
-
- Close
